Global Gastrointestinal Drugs Market Insights, Forecast to 2025

Global Gastrointestinal Drugs Market Insights, Forecast to 2025

Table of Contents
1 Study Coverage
1.1 Gastrointestinal Drugs Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Gastrointestinal Drugs Market Size Growth Rate by Product
1.4.2 Prescription Gastrointestinal Drug
1.4.3 OTC Gastrointestinal Drug
1.5 Market by End User
1.5.1 Global Gastrointestinal Drugs Market Size Growth Rate by End User
1.5.2 Chronic Gastritis
1.5.3 Functional Dyspepsia
1.5.4 Peptic Ulcer
1.5.5 Acute Gastroenteritis
1.5.6 Other
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Gastrointestinal Drugs Market Size
2.1.1 Global Gastrointestinal Drugs Revenue 2014-2025
2.1.2 Global Gastrointestinal Drugs Sales 2014-2025
2.2 Gastrointestinal Drugs Growth Rate by Regions
2.2.1 Global Gastrointestinal Drugs Sales by Regions
2.2.2 Global Gastrointestinal Drugs Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Gastrointestinal Drugs Sales by Manufacturers
3.1.1 Gastrointestinal Drugs Sales by Manufacturers
3.1.2 Gastrointestinal Drugs Sales Market Share by Manufacturers
3.1.3 Global Gastrointestinal Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Gastrointestinal Drugs Revenue by Manufacturers
3.2.1 Gastrointestinal Drugs Revenue by Manufacturers (2014-2019)
3.2.2 Gastrointestinal Drugs Revenue Share by Manufacturers (2014-2019)
3.3 Gastrointestinal Drugs Price by Manufacturers
3.4 Gastrointestinal Drugs Manufacturing Base Distribution, Product Types
3.4.1 Gastrointestinal Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Gastrointestinal Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Gastrointestinal Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Gastrointestinal Drugs Sales by Product
4.2 Global Gastrointestinal Drugs Revenue by Product
4.3 Gastrointestinal Drugs Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Gastrointestinal Drugs Breakdown Data by End User
6 North America
6.1 North America Gastrointestinal Drugs by Countries
6.1.1 North America Gastrointestinal Drugs Sales by Countries
6.1.2 North America Gastrointestinal Drugs Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Gastrointestinal Drugs by Product
6.3 North America Gastrointestinal Drugs by End User
7 Europe
7.1 Europe Gastrointestinal Drugs by Countries
7.1.1 Europe Gastrointestinal Drugs Sales by Countries
7.1.2 Europe Gastrointestinal Drugs Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Gastrointestinal Drugs by Product
7.3 Europe Gastrointestinal Drugs by End User
8 Asia Pacific
8.1 Asia Pacific Gastrointestinal Drugs by Countries
8.1.1 Asia Pacific Gastrointestinal Drugs Sales by Countries
8.1.2 Asia Pacific Gastrointestinal Drugs Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Gastrointestinal Drugs by Product
8.3 Asia Pacific Gastrointestinal Drugs by End User
9 Central & South America
9.1 Central & South America Gastrointestinal Drugs by Countries
9.1.1 Central & South America Gastrointestinal Drugs Sales by Countries
9.1.2 Central & South America Gastrointestinal Drugs Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Gastrointestinal Drugs by Product
9.3 Central & South America Gastrointestinal Drugs by End User
10 Middle East and Africa
10.1 Middle East and Africa Gastrointestinal Drugs by Countries
10.1.1 Middle East and Africa Gastrointestinal Drugs Sales by Countries
10.1.2 Middle East and Africa Gastrointestinal Drugs Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Gastrointestinal Drugs by Product
10.3 Middle East and Africa Gastrointestinal Drugs by End User
11 Company Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Details
11.1.2 Company Business Overview
11.1.3 AstraZeneca Gastrointestinal Drugs Sales, Revenue and Gross Margin (2014-2019)
11.1.4 AstraZeneca Gastrointestinal Drugs Products Offered
11.1.5 AstraZeneca Recent Development
11.2 Sanofi
11.2.1 Sanofi Company Details
11.2.2 Company Business Overview
11.2.3 Sanofi Gastrointestinal Drugs Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Sanofi Gastrointestinal Drugs Products Offered
11.2.5 Sanofi Recent Development
11.3 Bayer
11.3.1 Bayer Company Details
11.3.2 Company Business Overview
11.3.3 Bayer Gastrointestinal Drugs Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Bayer Gastrointestinal Drugs Products Offered
11.3.5 Bayer Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Company Business Overview
11.4.3 Pfizer Gastrointestinal Drugs Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Pfizer Gastrointestinal Drugs Products Offered
11.4.5 Pfizer Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Details
11.5.2 Company Business Overview
11.5.3 GlaxoSmithKline Gastrointestinal Drugs Sales, Revenue and Gross Margin (2014-2019)
11.5.4 GlaxoSmithKline Gastrointestinal Drugs Products Offered
11.5.5 GlaxoSmithKline Recent Development
11.6 Teva
11.6.1 Teva Company Details
11.6.2 Company Business Overview
11.6.3 Teva Gastrointestinal Drugs Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Teva Gastrointestinal Drugs Products Offered
11.6.5 Teva Recent Development
11.7 Zeria(Tillotts)
11.7.1 Zeria(Tillotts) Company Details
11.7.2 Company Business Overview
11.7.3 Zeria(Tillotts) Gastrointestinal Drugs Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Zeria(Tillotts) Gastrointestinal Drugs Products Offered
11.7.5 Zeria(Tillotts) Recent Development
11.8 Perrigo
11.8.1 Perrigo Company Details
11.8.2 Company Business Overview
11.8.3 Perrigo Gastrointestinal Drugs Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Perrigo Gastrointestinal Drugs Products Offered
11.8.5 Perrigo Recent Development
11.9 Boehringer Ingelheim
11.9.1 Boehringer Ingelheim Company Details
11.9.2 Company Business Overview
11.9.3 Boehringer Ingelheim Gastrointestinal Drugs Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Boehringer Ingelheim Gastrointestinal Drugs Products Offered
11.9.5 Boehringer Ingelheim Recent Development
11.10 Purdue Pharma
11.10.1 Purdue Pharma Company Details
11.10.2 Company Business Overview
11.10.3 Purdue Pharma Gastrointestinal Drugs Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Purdue Pharma Gastrointestinal Drugs Products Offered
11.10.5 Purdue Pharma Recent Development
11.11 C.B. Fleet
11.12 Abbott
11.13 Jiangzhong
11.14 Xian-Janssen
12 Future Forecast
12.1 Gastrointestinal Drugs Market Forecast by Regions
12.1.1 Global Gastrointestinal Drugs Sales Forecast by Regions 2019-2025
12.1.2 Global Gastrointestinal Drugs Revenue Forecast by Regions 2019-2025
12.2 Gastrointestinal Drugs Market Forecast by Product
12.2.1 Global Gastrointestinal Drugs Sales Forecast by Product 2019-2025
12.2.2 Global Gastrointestinal Drugs Revenue Forecast by Product 2019-2025
12.3 Gastrointestinal Drugs Market Forecast by End User
12.4 North America Gastrointestinal Drugs Forecast
12.5 Europe Gastrointestinal Drugs Forecast
12.6 Asia Pacific Gastrointestinal Drugs Forecast
12.7 Central & South America Gastrointestinal Drugs Forecast
12.8 Middle East and Africa Gastrointestinal Drugs Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Gastrointestinal Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables and Figures
Figure Gastrointestinal Drugs Product Picture
Table Gastrointestinal Drugs Market Segments
Table Key Manufacturers Gastrointestinal Drugs Covered
Table Global Gastrointestinal Drugs Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Gastrointestinal Drugs Sales Market Share by Product 2014-2025
Figure Prescription Gastrointestinal Drug Product Picture
Table Major Manufacturers of Prescription Gastrointestinal Drug
Figure OTC Gastrointestinal Drug Product Picture
Table Major Manufacturers of OTC Gastrointestinal Drug
Table Global Gastrointestinal Drugs Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Chronic Gastritis
Figure Functional Dyspepsia
Figure Peptic Ulcer
Figure Acute Gastroenteritis
Figure Other
Figure Gastrointestinal Drugs Report Years Considered
Figure Global Gastrointestinal Drugs Market Size 2014-2025 (Million US$)
Figure Global Gastrointestinal Drugs Sales 2014-2025 (K Units)
Table Global Gastrointestinal Drugs Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Gastrointestinal Drugs Sales by Regions 2014-2019 (K Units)
Table Global Gastrointestinal Drugs Sales Market Share by Regions 2014-2019
Figure Global Gastrointestinal Drugs Sales Market Share by Regions 2014-2019
Figure 2018 Global Gastrointestinal Drugs Sales Market Share by Regions
Table Global Gastrointestinal Drugs Revenue by Regions 2014-2019 (Million US$)
Table Global Gastrointestinal Drugs Revenue Market Share by Regions 2014-2019
Figure Global Gastrointestinal Drugs Revenue Market Share by Regions 2014-2019
Figure 2018 Global Gastrointestinal Drugs Revenue Market Share by Regions
Table Global Gastrointestinal Drugs Sales by Manufacturers (2014-2019) (K Units)
Table Global Gastrointestinal Drugs Sales Share by Manufacturers (2014-2019)
Figure Global Gastrointestinal Drugs Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Gastrointestinal Drugs Revenue by Manufacturers (2014-2019) (Million USD)
Table Gastrointestinal Drugs Revenue Share by Manufacturers (2014-2019)
Figure Gastrointestinal Drugs Value Share by Manufacturers in 2018
Table Key Manufacturers Gastrointestinal Drugs Price (2014-2019) (USD/Unit)
Table Gastrointestinal Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Gastrointestinal Drugs Product Type
Table Date of International Manufacturers Enter into Gastrointestinal Drugs Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Gastrointestinal Drugs Sales by Product (2014-2019) (K Units)
Table Global Gastrointestinal Drugs Sales Share by Product (2014-2019)
Figure Global Gastrointestinal Drugs Sales Market Share by Product (2014-2019)
Figure Global Gastrointestinal Drugs Sales Market Share by Product in 2018
Table Global Gastrointestinal Drugs Revenue by Product (2014-2019) (Million US$)
Table Global Gastrointestinal Drugs Revenue Share by Product (2014-2019)
Figure Global Gastrointestinal Drugs Revenue Market Share by Product (2014-2019)
Figure Global Gastrointestinal Drugs Revenue Market Share by Product in 2018
Table Gastrointestinal Drugs Price by Product 2014-2019 (USD/Unit)
Table Global Gastrointestinal Drugs Sales by End User (2014-2019) (K Units)
Table Global Gastrointestinal Drugs Sales Share by End User (2014-2019)
Figure Global Sales Gastrointestinal Drugs Market Share by End User (2014-2019)
Figure Global Sales Gastrointestinal Drugs Market Share by End User in 2018
Figure North America Gastrointestinal Drugs Sales Growth Rate 2014-2019 (K Units)
Figure North America Gastrointestinal Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table North America Gastrointestinal Drugs Sales by Countries (2014-2019) (K Units)
Table North America Gastrointestinal Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 North America Gastrointestinal Drugs Sales Market Share by Countries
Table North America Gastrointestinal Drugs Revenue by Countries (2014-2019) (Million US$)
Table North America Gastrointestinal Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Gastrointestinal Drugs Revenue Market Share by Countries
Figure United States Gastrointestinal Drugs Sales Growth Rate (2014-2019) (K Units)
Figure United States Gastrointestinal Drugs Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Gastrointestinal Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Canada Gastrointestinal Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Gastrointestinal Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Gastrointestinal Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table North America Gastrointestinal Drugs Sales by Product (2014-2019) (K Units)
Table North America Gastrointestinal Drugs Sales Market Share by Product (2014-2019)
Figure 2018 North America Gastrointestinal Drugs Market Share by Product
Table North America Gastrointestinal Drugs Sales by End User (2014-2019) (K Units)
Table North America Gastrointestinal Drugs Sales Market Share by End User (2014-2019)
Figure 2018 North America Gastrointestinal Drugs Market Share by End User
Figure Europe Gastrointestinal Drugs Sales Growth Rate 2014-2019 (K Units)
Figure Europe Gastrointestinal Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Gastrointestinal Drugs Sales by Countries (2014-2019) (K Units)
Table Europe Gastrointestinal Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Gastrointestinal Drugs Sales Market Share by Countries
Table Europe Gastrointestinal Drugs Revenue by Countries (2014-2019) (Million US$)
Table Europe Gastrointestinal Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Gastrointestinal Drugs Revenue Market Share by Countries
Figure Germany Gastrointestinal Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Germany Gastrointestinal Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure France Gastrointestinal Drugs Sales Growth Rate (2014-2019) (K Units)
Figure France Gastrointestinal Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Gastrointestinal Drugs Sales Growth Rate (2014-2019) (K Units)
Figure UK Gastrointestinal Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Gastrointestinal Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Italy Gastrointestinal Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Gastrointestinal Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Russia Gastrointestinal Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Gastrointestinal Drugs Sales by Product (2014-2019) (K Units)
Table Europe Gastrointestinal Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Europe Gastrointestinal Drugs Market Share by Product
Table Europe Gastrointestinal Drugs Sales by End User (2014-2019) (K Units)
Table Europe Gastrointestinal Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Europe Gastrointestinal Drugs Market Share by End User
Figure Asia Pacific Gastrointestinal Drugs Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Gastrointestinal Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Gastrointestinal Drugs Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Gastrointestinal Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Gastrointestinal Drugs Sales Market Share by Countries
Table Asia Pacific Gastrointestinal Drugs Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Gastrointestinal Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Gastrointestinal Drugs Revenue Market Share by Countries
Figure China Gastrointestinal Drugs Sales Growth Rate (2014-2019) (K Units)
Figure China Gastrointestinal Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Gastrointestinal Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Japan Gastrointestinal Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Gastrointestinal Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Korea Gastrointestinal Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure India Gastrointestinal Drugs Sales Growth Rate (2014-2019) (K Units)
Figure India Gastrointestinal Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Gastrointestinal Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Australia Gastrointestinal Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Gastrointestinal Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Gastrointestinal Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Gastrointestinal Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Gastrointestinal Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Gastrointestinal Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Gastrointestinal Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Gastrointestinal Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Gastrointestinal Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Gastrointestinal Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Gastrointestinal Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Gastrointestinal Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Gastrointestinal Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Gastrointestinal Drugs Sales by Product (2014-2019) (K Units)
Table Asia Pacific Gastrointestinal Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Gastrointestinal Drugs Market Share by Product
Table Asia Pacific Gastrointestinal Drugs Sales by End User (2014-2019) (K Units)
Table Asia Pacific Gastrointestinal Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Gastrointestinal Drugs Market Share by End User
Figure Central & South America Gastrointestinal Drugs Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Gastrointestinal Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Gastrointestinal Drugs Sales by Countries (2014-2019) (K Units)
Table Central & South America Gastrointestinal Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Gastrointestinal Drugs Sales Market Share by Countries
Table Central & South America Gastrointestinal Drugs Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Gastrointestinal Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Gastrointestinal Drugs Revenue Market Share by Countries
Figure Brazil Gastrointestinal Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Gastrointestinal Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Gastrointestinal Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Gastrointestinal Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Gastrointestinal Drugs Sales by Product (2014-2019) (K Units)
Table Central & South America Gastrointestinal Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Gastrointestinal Drugs Market Share by Product
Table Central & South America Gastrointestinal Drugs Sales by End User (2014-2019) (K Units)
Table Central & South America Gastrointestinal Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Gastrointestinal Drugs Market Share by End User
Figure Middle East and Africa Gastrointestinal Drugs Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Gastrointestinal Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Gastrointestinal Drugs Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Gastrointestinal Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Gastrointestinal Drugs Sales Market Share by Countries
Table Middle East and Africa Gastrointestinal Drugs Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Gastrointestinal Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Gastrointestinal Drugs Revenue Market Share by Countries
Figure GCC Countries Gastrointestinal Drugs Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Gastrointestinal Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Gastrointestinal Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Gastrointestinal Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Gastrointestinal Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Gastrointestinal Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Gastrointestinal Drugs Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Gastrointestinal Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Gastrointestinal Drugs Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Gastrointestinal Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Gastrointestinal Drugs Market Share by Product
Table Middle East and Africa Gastrointestinal Drugs Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Gastrointestinal Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Gastrointestinal Drugs Market Share by End User
Table AstraZeneca Company Details
Table AstraZeneca Gastrointestinal Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table AstraZeneca Recent Development
Table Sanofi Company Details
Table Sanofi Gastrointestinal Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Sanofi Recent Development
Table Bayer Company Details
Table Bayer Gastrointestinal Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Bayer Recent Development
Table Pfizer Company Details
Table Pfizer Gastrointestinal Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Pfizer Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Gastrointestinal Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table GlaxoSmithKline Recent Development
Table Teva Company Details
Table Teva Gastrointestinal Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Teva Recent Development
Table Zeria(Tillotts) Company Details
Table Zeria(Tillotts) Gastrointestinal Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Zeria(Tillotts) Recent Development
Table Perrigo Company Details
Table Perrigo Gastrointestinal Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Perrigo Recent Development
Table Boehringer Ingelheim Company Details
Table Boehringer Ingelheim Gastrointestinal Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Boehringer Ingelheim Recent Development
Table Purdue Pharma Company Details
Table Purdue Pharma Gastrointestinal Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Purdue Pharma Recent Development
Table C.B. Fleet Company Details
Table Abbott Company Details
Table Jiangzhong Company Details
Table Xian-Janssen Company Details
Table Global Gastrointestinal Drugs Sales Forecast by Regions 2019-2025 (K Units)
Table Global Gastrointestinal Drugs Sales Market Share Forecast by Regions 2019-2025
Table Global Gastrointestinal Drugs Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Gastrointestinal Drugs Revenue Market Share Forecast by Regions 2019-2025
Table Global Gastrointestinal Drugs Sales Forecast by Product 2019-2025 (K Units)
Table Global Gastrointestinal Drugs Sales Market Share Forecast by Product 2019-2025
Table Global Gastrointestinal Drugs Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Gastrointestinal Drugs Revenue Market Share Forecast by Product 2019-2025
Table Global Gastrointestinal Drugs Sales Forecast by End User 2019-2025 (K Units)
Table Global Gastrointestinal Drugs Sales Market Share Forecast by End User 2019-2025
Figure North America Gastrointestinal Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Gastrointestinal Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Gastrointestinal Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Gastrointestinal Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Gastrointestinal Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Gastrointestinal Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Gastrointestinal Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Gastrointestinal Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Gastrointestinal Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Gastrointestinal Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Gastrointestinal Drugs Value Chain
Table Gastrointestinal Drugs Customers List
Table Gastrointestinal Drugs Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Anti-Peptic Ulcer Drugs Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 110

According to our LPI (LP Information) latest study, the global Anti-Peptic Ulcer Drugs market size was valued at US$ 8523.5 million in 2023. With growing demand in downstream market, the Anti-Peptic Ulcer Drugs is forecast to a readjusted size of US$ 21200 million by 2030 with a CAGR of 13.9% during review period. The research report highlights the growth potential of the global Anti-Peptic Ulcer Drugs market. Anti-Peptic Ulcer Drugs are expected to show stable growth in the future marke......

Global Lansoprazole Market Research Report 2024

Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 102

The Lansoprazole market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Lansoprazole market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the comp......

Global Irritable Bowel Syndrome (IBS) Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 88

According to our LPI (LP Information) latest study, the global Irritable Bowel Syndrome (IBS) market size was valued at US$ 4634.2 million in 2023. With growing demand in downstream market, the Irritable Bowel Syndrome (IBS) is forecast to a readjusted size of US$ 12750 million by 2030 with a CAGR of 15.6% during review period. The research report highlights the growth potential of the global Irritable Bowel Syndrome (IBS) market. Irritable Bowel Syndrome (IBS) are expected to show stabl......

Global Esomeprazole Market Research Report 2024

Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 89

The Esomeprazole market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Esomeprazole market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the comp......

Global Irritable Bowel Syndrome (IBS) Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 02-Jan-2024        Price: US 3380 Onwards        Pages: 126

Market Overview of Global Irritable Bowel Syndrome (IBS) market: According to our latest research, the global Irritable Bowel Syndrome (IBS) market looks promising in the next 5 years. As of 2022, the global Irritable Bowel Syndrome (IBS) market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive anal......

Global Diarrhea Drug Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 109

Market Overview of Global Diarrhea Drug market: According to our latest research, the global Diarrhea Drug market looks promising in the next 5 years. As of 2022, the global Diarrhea Drug market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Diarrhea Drug market, with a sys......

Drugs for Traveler's Diarrhea - Global Market Insights and Sales Trends 2024

Published: 27-Dec-2023        Price: US 3350 Onwards        Pages: 96

This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Drugs for Traveler's Diarrhea, with bo......

Global Lansoprazole Professional Survey Report 2023, Forecast to 2028

Published: 26-Dec-2023        Price: US 3280 Onwards        Pages: 136

Lansoprazole reduces the amount of acid your stomach makes. It's used for indigestion, heartburn and acid reflux and gastroesophageal-reflux-disease (GORD). Lansoprazole is also taken to prevent and treat stomach ulcers. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their g......

Global Pentasa (Ulcerative Colitis) Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 113

Market Overview of Global Pentasa (Ulcerative Colitis) market: According to our latest research, the global Pentasa (Ulcerative Colitis) market looks promising in the next 5 years. As of 2022, the global Pentasa (Ulcerative Colitis) market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis o......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs